|
Gender (M/F)
|
24/25
|
|
Age (year)
|
74.5 ± 11.2
|
|
Duration of HD (year)
|
3.4 (2.1–7.2)
|
|
Primary cause of ESKD, n (%)
|
|
Chronic glomerulonephritis
|
8 (16.3)
|
|
Diabetic nephropathy
|
22 (44.9)
|
|
Nephrosclerosis
|
10 (20.4)
|
|
Unknown and others
|
9 (18.4)
|
|
Hypertension, n (%)
|
41 (83.7)
|
|
Diabetes mellitus, n (%)
|
21 (42.9)
|
|
Dyslipidemia, n (%)
|
10 (20.4)
|
|
Atrial fibrillation, n (%)
|
6 (12.2)
|
|
Use of antihypertensive drug, n (%)
|
38 (77.6)
|
|
History of coronary artery disease, n (%)
|
|
PCI
|
4 (8.2)
|
|
CABG
|
3 (6.1)
|
|
Vascular access
| |
|
Arteriovenous fistula
|
43 (87.8)
|
|
Arteriovenous graft
|
2 (4.1)
|
|
Subcutaneously fixed superficial artery
|
2 (4.1)
|
|
Venous catheter
|
2 (4.1)
|
|
Body weight (kg)
|
52.7 ± 11.5
|
|
Systolic blood pressure (mmHg)
|
141 ± 26
|
|
Diastolic blood pressure (mmHg)
|
73 ± 16
|
|
Heart rate (beat/minute)
|
75 ± 13
|
|
Ejection fraction (%)
|
60 ± 12
|
|
B-lines (number)
|
10.8 ± 4.6
|
